Skip to main content
Jinjuan Yao, MD, Pathology, New York, NY

Jinjuan Yao MD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology


Physician

Request Appointment
  • 1275 York AvenueNew York, NY 10065

  • Book by Phone+1(484) 261-3225

Overview of  Dr. Yao

Dr. Jinjuan Yao is a pathologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Shanxi Medical University and has been in practice 32 years. She is one of 169 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pathology. She has more than 30 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Molecular Genetic Pathology, 2013 - 2014
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Pathology-Anatomic and Clinical, 2009 - 2013
  • Shanxi Medical University
    Shanxi Medical UniversityClass of 1994

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2021 - 2027
  • NY State Medical License
    NY State Medical License 2013 - 2027
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Pathology - Hematology
    American Board of Pathology Pathology - Hematology
  • Pathology - Molecular Genetic
    American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Abstracts/Posters

  • Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a Spike-in Clonal Sequence
    Jin Juan Yao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • CAP Highlights Molecular Testing in Complex Cancer Diagnoses
    CAP Highlights Molecular Testing in Complex Cancer DiagnosesJanuary 31st, 2026
  • Scenario 1. Molecular Profiling in the Workup for Cancer of Unknown Primary (CUP)
    Scenario 1. Molecular Profiling in the Workup for Cancer of Unknown Primary (CUP)February 4th, 2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: